Yaofeng Cheng

819 total citations
17 papers, 570 citations indexed

About

Yaofeng Cheng is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Yaofeng Cheng has authored 17 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Pharmacology. Recurrent topics in Yaofeng Cheng's work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (8 papers) and HIV/AIDS drug development and treatment (4 papers). Yaofeng Cheng is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (8 papers) and HIV/AIDS drug development and treatment (4 papers). Yaofeng Cheng collaborates with scholars based in United States, Germany and China. Yaofeng Cheng's co-authors include Yurong Lai, Daniel A.J. Bow, Dietrich Keppler, Johan Palm, Keith Hoffmaster, Raymond Evers, Kim L. R. Brouwer, Bruno Stieger, Ryan M. Pelis and W. Griffith Humphreys and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics and American Journal of Physiology-Renal Physiology.

In The Last Decade

Yaofeng Cheng

17 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaofeng Cheng United States 10 394 238 165 110 57 17 570
Masakazu Hirouchi Japan 12 363 0.9× 216 0.9× 167 1.0× 132 1.2× 43 0.8× 17 586
Krisztina Herédi‐Szabó Hungary 15 457 1.2× 221 0.9× 179 1.1× 142 1.3× 57 1.0× 21 644
Jenny M. Pedersen Sweden 8 590 1.5× 292 1.2× 221 1.3× 142 1.3× 54 0.9× 11 754
Nobuko Ohmoto Japan 11 470 1.2× 252 1.1× 165 1.0× 188 1.7× 29 0.5× 13 774
Katja Damme Germany 6 366 0.9× 197 0.8× 87 0.5× 143 1.3× 34 0.6× 8 504
Dominic Surry United Kingdom 16 354 0.9× 169 0.7× 269 1.6× 146 1.3× 24 0.4× 19 639
Émilie Jigorel France 6 410 1.0× 165 0.7× 250 1.5× 115 1.0× 66 1.2× 6 593
Takuro Niwa Japan 11 436 1.1× 207 0.9× 188 1.1× 219 2.0× 87 1.5× 16 824
Janett Müller Germany 10 318 0.8× 155 0.7× 146 0.9× 153 1.4× 41 0.7× 13 532
Maria M. Posada United States 12 268 0.7× 117 0.5× 159 1.0× 119 1.1× 36 0.6× 24 509

Countries citing papers authored by Yaofeng Cheng

Since Specialization
Citations

This map shows the geographic impact of Yaofeng Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaofeng Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaofeng Cheng more than expected).

Fields of papers citing papers by Yaofeng Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaofeng Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaofeng Cheng. The network helps show where Yaofeng Cheng may publish in the future.

Co-authorship network of co-authors of Yaofeng Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yaofeng Cheng. A scholar is included among the top collaborators of Yaofeng Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaofeng Cheng. Yaofeng Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Awad, Mark M., Jerome H. Goldschmidt, Alexander I. Spira, et al.. (2023). Abstract C026: Initial safety, pharmacokinetics, and recommended Phase 2 dose from RAMP 203: A Phase 1/2 study of Avutometinib + Sotorasib in KRAS G12C Mutant Non-Small Cell Lung Cancer. Molecular Cancer Therapeutics. 22(12_Supplement). C026–C026. 4 indexed citations
2.
Zhou, Meiling, Jiaoya Xi, Yaofeng Cheng, et al.. (2021). Reprogrammed mesenchymal stem cells derived from iPSCs promote bone repair in steroid-associated osteonecrosis of the femoral head. Stem Cell Research & Therapy. 12(1). 175–175. 53 indexed citations
3.
Cheng, Yaofeng, Xiaomin Liang, Hao Jia, Congrong Niu, & Yurong Lai. (2021). Application of a PBPK model to elucidate the changes of systemic and liver exposures for rosuvastatin, carotegrast, and bromfenac followed by OATP inhibition in monkeys. Clinical and Translational Science. 14(5). 1924–1934. 6 indexed citations
4.
Cheng, Yaofeng, Shen-Jue Chen, Weiqi Chen, et al.. (2017). Bile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of Troglitazone. Journal of Pharmacology and Experimental Therapeutics. 362(3). 385–394. 8 indexed citations
5.
Cheng, Yaofeng, Lifei Wang, Lisa Iacono, et al.. (2017). Clinical significance of CYP2C19 polymorphisms on the metabolism and pharmacokinetics of 11β‐hydroxysteroid dehydrogenase type‐1 inhibitor BMS‐823778. British Journal of Clinical Pharmacology. 84(1). 130–141. 8 indexed citations
6.
Shen, Hong, Jungui Dai, Yaofeng Cheng, et al.. (2016). Coproporphyrins I and III as Functional Markers of OATP1B Activity: In Vitro and In Vivo Evaluation in Preclinical Species. Journal of Pharmacology and Experimental Therapeutics. 357(2). 382–393. 104 indexed citations
7.
Cheng, Yaofeng, Yueping Zhang, Hong Shen, et al.. (2016). Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment. Biopharmaceutics & Drug Disposition. 37(5). 276–286. 14 indexed citations
8.
Cheng, Yaofeng, Ayman El‐Kattan, Yan Zhang, Adrian S. Ray, & Yurong Lai. (2016). Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and Development. Chemical Research in Toxicology. 29(4). 545–563. 20 indexed citations
9.
Cheng, Yaofeng, Thomas F. Woolf, Jinping Gan, & Kan He. (2015). In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review. Chemico-Biological Interactions. 255. 23–30. 26 indexed citations
10.
Brouwer, Kim L. R., Dietrich Keppler, Keith Hoffmaster, et al.. (2013). In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development. Clinical Pharmacology & Therapeutics. 94(1). 95–112. 191 indexed citations
11.
Pelis, Ryan M., et al.. (2012). Functional significance of conserved cysteines in the human organic cation transporter 2. American Journal of Physiology-Renal Physiology. 303(2). F313–F320. 14 indexed citations
12.
Cheng, Yaofeng, et al.. (2011). Expression of Organic Anion Transporter 2 in the Human Kidney and Its Potential Role in the Tubular Secretion of Guanine-Containing Antiviral Drugs. Drug Metabolism and Disposition. 40(3). 617–624. 67 indexed citations
14.
Knudsen, Gabriel A., Yaofeng Cheng, Robert K. Kuester, Michelle J. Hooth, & I.G. Sipes. (2009). Effects of Dose and Route on the Disposition and Kinetics of 1-Butyl-1-methylpyrrolidinium Chloride in Male F-344 Rats. Drug Metabolism and Disposition. 37(11). 2171–2177. 9 indexed citations
15.
Cheng, Yaofeng, Stephen H. Wright, Michelle J. Hooth, & I.G. Sipes. (2009). Characterization of the Disposition and Toxicokinetics of N-Butylpyridinium Chloride in Male F-344 Rats and Female B6C3F1 Mice and Its Transport by Organic Cation Transporter 2. Drug Metabolism and Disposition. 37(4). 909–916. 21 indexed citations
16.
Chen, Donghui, et al.. (2004). [Effect of Spatholobus suberectus on the bone marrow cells and related cytokines of mice].. PubMed. 29(4). 352–5. 9 indexed citations
17.
Chun, Ze, et al.. (2004). [The influence of Bazhen decoction on hematopoietic modulator in anaemic mice].. PubMed. 21(5). 727–31. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026